Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Spironolactone may help reduce hair loss in androgenic alopecia.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Balding men have higher heart disease risk.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

AGA patients have higher heart disease risk.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Serenoa repens (saw palmetto) may cause side effects like hot flashes in children and needs more research for safety in pediatric use.

Honokiol might help reduce male skin aging by maintaining testosterone levels.